From Filling to Regeneration: The Shift in Modern Aesthetics

For years, injectable aesthetics focused on one thing: adding volume. Today, both practitioners and patients are asking for more — results that look natural, last longer, and improve the underlying health of the skin. This shift, from surface correction to biological renewal, is what we call regenerative aesthetics.

Why the market is changing

Industry market research points to sustained double-digit growth in facial injectables through the early 2030s, driven by demand for minimally invasive treatments. Within that, the fastest-growing segments are regenerative — biostimulators and repair injectables — rather than filling alone.

Aging is more than lost volume

Skin aging involves collagen loss, degradation of the extracellular matrix (ECM), declining elasticity and reduced repair capacity. Simply replacing volume does not address these underlying changes. Regenerative approaches aim to restore the skin's own ability to renew, repair and rebuild.

The regenerative logic

• Fibroblast activation — stimulating the cells that produce collagen and elastin.

• Collagen remodelling — supporting Type I and Type III collagen renewal for firmer, healthier skin.

• ECM renewal — improving the tissue microenvironment and its repair capacity.

Regeneration is not about adding more volume. It is about restoring the skin's own ability to renew, repair and rebuild — for natural-looking, longer-lasting results.